AIM ImmunoTech Completes All Treatments in Phase 1 Human Safety Study of Intranasal Administration of Ampligen
Company is Planning a Phase 2 Study of its Drug as a Broad-Spectrum Respiratory Virus Prophylaxis Nasal Profile An example...
Year: 2021
Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers
Demonstrates better anti-metastatic activity compared with docetaxel alone Company to host webcast on its oncology program today at 11:00 a.m....
Innocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum June 24th
The Company invites investors, advisors and analysts, to attend its real-time, interactive presentations on LifeSciencesInvestorForum.comHERZLIYA, Israel and CALGARY, Alberta, June...
Shield Therapeutics PLC (“Shield”) to Webcast Live at Life Sciences Investor Forum June 24th
Shield invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comLONDON, June...
VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comAUSTIN, Texas,...
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.comNEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Life...
Resonant Announces Upgraded WaveX™ Design Software for Acoustic Wave Filter Development, Specifically Enhanced for 5G, Wi-Fi, and Ultra-wideband RF Filters
Platform is now cloud-based with full 3D finite element modeling to enable XBAR® design workflow; enhancements enable simulation of resonators...
Cassava Sciences Provides Mid-Year Corporate Update, Clinical Development Progress and Announces Guidance on Clinical Data Release
Open-label Study Completes Patient EnrollmentCognition Maintenance Study Initiated May 2020, now 30% Enrolled6-month Biomarker Data to be Presented at AAIC...
All Smiles Here: Align Technology Introduces the Limited-Edition Charli D’Amelio x Invisalign® Aligner Case
Social Media Star Charli D’Amelio Partners with Align Technology’s Invisalign Brand to Transform More Smiles with its First Limited-Edition Product...
Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma
Treatment with OligoPhoreTM siRNA stops aggressive ATLL tumor growth to near zeroSignificant reduction in tumor size, spleen size and peripheral...
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors
Newly Established Site Advocacy Group will Deliver Deeper, More Meaningful Site-Based Insights to Drive Adoption of Decentralized Clinical Trials Methodologies...
OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
MIAMI, June 21, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has...
Celsion Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank
Improvement to the Balance Sheet Leverages Strong Equity Structure Retires Debt and Gains Five Months of Operating Runway at Very...
Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH
Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive...
Zogenix to Participate in Two Upcoming Investor Conferences
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease...
Alignment Healthcare Receives Conditional Approval to Expand Product Lines That Serve Individuals With Lower Incomes and Chronic Illnesses in 2022
ORANGE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced a significant expansion...
T2 Biosystems to Participate at Clinical Conferences in June and July 2021
Company will underscore the importance of rapid diagnostic technology for detecting bloodstream infections (BSIs) and sepsisLEXINGTON, Mass., June 21, 2021...
Arbor Biotechnologies to Present at the Raymond James Human Health Innovation Conference
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next...
Industry Leaders Join 23andMe Board of Directors
Dr. Valerie Montgomery Rice and Peter Taylor Join 23andMe’s Board as the Company Sets to Accelerate Personalized Healthcare Based on...
C4 Therapeutics Presents Pre-clinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the 16th Annual International Conference on Malignant Lymphoma
– CFT7455 Demonstrated High Binding Affinity to Cereblon and Target Selectivity in Non-Hodgkin’s Lymphoma Cell Models, Producing Rapid and Deep...